Jyothy Labs Limited (JYOTHYLAB)

Fast Moving Consumer Goods · Household Products · NSE · Updated 13 August 2026

By StockFin Research Team • AI-Assisted Analysis • Source: BSE/NSE Filings

₹200.27 ↓ 39.81% (1Y)

🎯 Key Takeaways

Jyothy Labs is navigating a phase of cautious recovery, marked by modest top-line growth and margin stabilization after a period of pressure. Management is prioritizing innovation, premiumisation, and cost management to drive sustainable growth, while divesting non-core assets like the Jammu facility to optimize capital allocation.
Revenue declined 4% QoQ to ₹704 in Q3FY25.
⚠️ Margin recovery is contingent on input cost moderation and successful pricing initiatives, which are not guaranteed in a competitive FMCG landscape.

Market Cap

₹8,053

P/E Ratio

21.6

Div Yield

0.00%

Promoter

0.0%

✨ Ask AI About JYOTHYLAB 📊 Interactive Charts

📖 The Story

Jyothy Labs is navigating a phase of cautious recovery, marked by modest top-line growth and margin stabilization after a period of pressure. Management is prioritizing innovation, premiumisation, and cost management to drive sustainable growth, while divesting non-core assets like the Jammu facility to optimize capital allocation.

📰 What's Happening

In Q1 FY27, Jyothy Labs reported 3.0% YoY revenue growth to ₹773 crores, with core segments (excluding Pril and Fa) growing 8.1% in value and 5.3% in volume, driven by 14.1% growth in Fabric Care and 2.4% in Home Care. Despite inflationary pressures, EBITDA margin held at 8.4% and PAT reached ₹47.6 crores. The Board approved the transfer of leasehold rights in the Jammu facility for ₹9.93 crores, targeting completion by March 31, 2027. At the 35th AGM, management emphasized volume growth, Exo brand development as an owned platform, and ESG initiatives, while reappointing Aditya Sapru and declaring a final dividend of Rs. 3.50 per share.

Source: Stock Announcements

📊 Quarterly Results (₹ Cr)

Metric	Q4FY23	Q1FY24	Q2FY24	Q3FY24	Q4FY24	Q1FY25	Q2FY25	Q3FY25
Revenue	617	687	732	678	660	742	734	704
Operating Profit	97	134	149	129	121	147	151	130
OPM %	14.8%	17.1%	18.5%	17.5%	16.4%	18.0%	18.9%	16.4%
Net Profit	59	96	104	91	78	102	105	87
EPS	₹1.61	₹2.62	₹2.84	₹2.48	₹2.13	₹2.77	₹2.86	₹2.38

Revenue has shown sequential improvement from ₹660 crores in Q4FY24 to ₹773 crores in Q1FY27, but profitability remains under strain, with PAT declining to ₹47.6 crores from ₹105 crores in Q2FY25. Operating margins have stabilized around 8-9% after peaking above 18% in prior quarters, reflecting persistent cost pressures. Management attributes margin recovery to moderating input costs and strategic pricing, but near-term profitability appears to be trading off for volume resilience in a competitive FMCG environment.

🔮 Management Outlook & What's Next

Management expects margin improvement in FY27 as input cost inflation moderates, supported by innovation, premiumisation, and calibrated pricing actions. They highlighted resilience in core segments and sustainable growth prospects, with a focus on operational efficiency and brand-led growth through platforms like Exo. No specific revenue or margin targets were provided, but confidence in long-term recovery is underpinned by volume trends and product mix optimization.

Extracted from official company announcements. Not StockFin.ai's opinion.

⚖️ Peer Comparison — Household Products

Company	MCap (₹ Cr)	P/E	ROCE	ROE	D/E
DOMS Industries Limited	13,737	64.9	—	—	—
Jyothy Labs Limited	8,053	21.6	—	—	—
Flair Writing Industries Limited	3,520	28.0	—	—	—
Navneet Education Limited	3,114	4.2	—	—	—
Eveready Industries India Limited	2,326	29.0	—	—	—
Kokuyo Camlin Limited	931	37.6	—	—	—
Linc Limited	575	15.3	—	—	—
Indo-National Limited	288	2.3	—	—	—
Sundaram Multi Pap Limited	65	56.7	—	—	—
Ambica Agarbathies & Aroma industries Limited	40	57.4	—	—	—

🔗 Peer Stock Analyses

DOMS FLAIR NAVNETEDUL EVEREADY KOKUYOCMLN

⚠️ Risk Factors

1. Margin recovery is contingent on input cost moderation and successful pricing initiatives, which are not guaranteed in a competitive FMCG landscape. 2. Reliance on core segments like Fabric Care, which faces volume growth challenges, poses execution risk. 3. Asset divestment may yield short-term gains but could signal underlying operational constraints in manufacturing. 4. High promoter pledging or regulatory scrutiny around related-party transactions (e.g., lease transfers) could introduce governance concerns.

📋 Recent Filings

🧠 Analyst's Read

Jyothy Labs is executing a disciplined but cautious turnaround, balancing volume growth with margin discipline amid inflation. Investors should monitor input cost trends, pace of innovation in core categories, and progress on Exo brand development as key catalysts. The company’s ability to sustainably grow profits while maintaining margins will be critical to reversing its recent underperformance.

Based on filing content and financial data. Not a recommendation.

Read the full analysis

Quarterly trends, balance sheet, cash flow, peer comparison, and AI insights — sign up free to unlock.

2 free AI queries per day.

✨ Deep Dive with AI on JYOTHYLAB

Data sourced from stock announcements. Analysis generated by StockFin.ai.
For informational purposes only — not investment advice. Updated 2026-08-13.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when JYOTHYLAB files new disclosures

Track JYOTHYLAB filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track JYOTHYLAB — Free

Free account · 2 AI queries/day